Answers are grounded in this paper and cite their sources.
Background and Purpose Dexamethasone, a first‐line treatment for neonatal respiratory distress syndrome (NRDS), promotes foetal lung maturation whilst simultaneously inducing neurotoxicity in offspring. We aimed to define the therapeutic window of dexamethasone for the treatment of NRDS. Experimental Approach Pregnant rats were given dexamethasone at 0.1 or 0.4 mg·kg −1 to simulate clinically equivalent prenatal dexamethasone exposure. Half of the rats were anaesthetised, and surfactant proteins A and B in foetal lungs quantified. A pharmacokinetic/pharmacodynamics (PK/PD) model was developed to determine the minimum effective concentration. The remaining rats, delivered naturally, and their offspring underwent open‐field testing. Messenger RNA sequencing of the foetal hippocampus was performed, and concentration‐toxicity assays were conducted using H19‐7/IGF‐IR cells. Data were integrated with a maternal‐foetal physiologically based pharmacokinetic (PBPK) model to determine the maximum tolerated concentration. A clinical PBPK for dexamethasone in pregnant women was used to simulate a potentially optimal dosing regimen. Key Results The PK/PD model adequately characterised dexamethasone‐induced foetal lung maturation and indicated a minimal effective concentration of 1.63 ng·ml −1 . The offspring of PDE rats exhibited significant behavioural changes. mRNA sequencing analysis suggested that neurotoxicity was mediated via the Wnt pathway and renin‐angiotensin system, with BDNF and CMA1 identified as potential biomarkers of neurotoxicity. Cell‐based assays suggested a neurotoxic threshold concentration of 17 ng·ml −1 . For a therapeutic window of 1.63–17 ng·ml −1 , PBPK model simulations indicated that a reduced dose regimen of 2.5 or 3 mg every 8 h for six doses may represent an optimised therapeutic strategy. Conclusion and Implications This model‐informed precision dosing strategy provides a rational approach to optimising clinical dexamethasone dosing regimens.
No takes yet. Share an insight, caveat, or question.
Song et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: